Roche Holding AG (XSWX:ROG)
CHF 251 0 (0%) Market Cap: 201.45 Bil Enterprise Value: 231.01 Bil PE Ratio: 18.96 PB Ratio: 6.91 GF Score: 93/100

Roche Holding AG Virtual Event on Key Evrysdi Data Presented at 2021 CureSMA Annual Meeting Transcript

Jun 14, 2021 / 02:00PM GMT
Release Date Price: CHF341.7 (-0.09%)
Operator

This meeting is being recorded. (Operator Instructions) At this time, it's my pleasure to introduce Karl Mahler, Head of Investor Relations and Group Planning. Karl, the stage is yours.

Karl Mahler
Roche Holding AG - Head of IR

Yes. Thanks a lot, Henrik. Welcome, everybody, to our fifth science call this year. We have 1 hour reserved for you, half an hour for presentation and half an hour for the Q&A. And of course, I mean if you find difficulties or have difficulties to enter into the Zoom system, which I don't assume now, but you can also, of course, drop an e-mail directly to [email protected].

So I'm joined today by Kathryn Wagner. She is the Vice President of Neuromuscular Disorders, Clinical Development with Roche. Many of you may know her from her previous jobs and engagement. She was a Director of the Center of Genetic Muscle Disorders of the Kennedy Krieger Institute. She was Professor at the Johns Hopkins University, and she is well-known for her initiatives in the whole CNS field, but in particular, on the Duchenne disease research.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot